Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Abstract Text:

AIMS: Coxsackievirus B3 (CVB3)-induced chronic myocarditis in mice is accompanied by severe fibrosis and by sustained elevation of platelet-derived growth factor (PDGF)-A, -B, and -C levels in the cardiac tissue. To test if PDGF stimulation of resident fibroblasts causally contributes to fibrosis, we employed inhibition of PDGF receptor signalling with the orally available kinase inhibitor Imatinib. METHODS AND RESULTS: Chronic myocarditis was induced by CVB3 infection of major histocompatibility complex (MHC) class II knockout (B6Aa(0)/Aa(0)) mice. The mice were treated with 100 mg/kg Imatinib or vehicle, respectively, twice daily for 34 days. Expression of PDGF-C and of inflammatory cytokines were analysed by semi-quantitative RT-PCR. PDGFalpha receptor phosphorylation was detected by immunoblotting of cardiac tissue extracts and in situ by immunohistochemistry. Fibrosis formation was analysed by Sirius-Red staining and hydroxyproline (HP) determination. Fibronectin, and tenascin expression was analysed by RT-PCR and immunohistochemistry. Matrix metalloproteinase (MMP) activity was assessed with collagen, synthetic peptides, and gelatine as substrates. Imatinib significantly inhibited the myocarditis-related PDGFalpha receptor activation in the heart tissue. The virus titres in the hearts, inflammatory infiltrations, and elevated PDGF levels were unaffected by the Imatinib treatment. A significant attenuation of fibrosis occurred in Imatinib-treated animals. The Sirius Red-stained fibrotic area was reduced from 5.30 +/- 0.50 to 3.21 +/- 0.35%, and the HP content was reduced from 362 +/- 43 to 238 +/- 32 microMol/10 mg dry weight vs. 190 +/- 27 in uninfected controls. The expression of fibronectin, EIIIA(+) fibronectin, and tenascin C were likewise reduced. The diminished matrix protein deposition was not caused by elevated MMP activity, since MMP activity was not changed or even reduced under Imatinib. CONCLUSION: The data suggest a causal role for elevated PDGF expression and PDGF receptor activity in the pathogenesis of cardiac fibrosis.

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cardiovascular research

VOLUME: 79

Page Numbers: 118-26

Journal Abbreviation: Cardiovasc. Res.

ISSN: 0008-6363

DAY: 7

MONTH: 03

YEAR: 2008

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 77427

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.

AFFILIATION: Institute of Virology, Medical Faculty, Friedrich Schiller University, Jena, Germany.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cardiovasc Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis Related Publications

• Adhesion and ultrasound-induced delivery from monodisperse microbubbles in a parallel plate flow cell.
• Diluting the hydrogen bonds in viscous solutions of n-butanol with n-bromobutane: A dielectric study.
• Fortification of eggs with folic acid as a possible contribution to enhance the folic acid status of populations.
• Fourfold [2]rotaxanes based on calix[4]arenes.
• Guest exchange in dimeric capsules formed by tetra-urea calix[4]arenes.
• Hydrostatic pressure in the inner ear fluid compartments and its effects on inner ear function.
• Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
• In Vitro Evaluation of the Cytotoxicity and Genotoxicity of Resorcylidene Aminoguanidine in Human Diploid Cells B-HNF-1.
• Inhibition of PDGFR tyrosine kinase activity by a series of novel N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides - A SAR study on the bioisosterism of pyrimidine and imidazole.
• Instantaneous frequency meter with averaging capability based on interval duration measurement.
• Lanthanide complexation with CMPO and CMPO-calix[4]arenes in solution: Spectrophotometric and electrospray mass spectrometric approaches.
• Light-in-flight holography for visualization and velocimetry in three-dimensional flows.
• Molecules with New Topologies Derived from Hydrogen-Bonded Dimers of Tetraurea Calix[4]arenes.
• Postimplantation analysis enables improvement of dose-volume histograms and reduction of toxicity for permanent seed implantation.
• Protein tyrosine phosphatases: regulatory mechanisms.
• Role of SHP2 for FLT3-dependent proliferation and transformation in 32D cells.
• Self-assembled dendrimers with uniform structure.
• Short latency vestibular evoked responses to linear acceleration stimuli in small mammals: masking effects and experimental applications.
• Stimulated echoes and two-dimensional nuclear magnetic resonance spectra for solids with simple line shapes.
• The structure of the 5'-end of the protein-tyrosine phosphatase PTPRJ mRNA reveals a novel mechanism for translation attenuation.
• [Clinical chemistry diagnosis of uric-acid metabolism disorders]
• [On differential diagnosis of hyperemesis gravidarum. (A clinical case contribution)]
• [The 1610 Wittenberg cesarean section]
• [Typical forms of choriocarcinoma in clinical practice--diagnosis and therapeutic course in four patients]